Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Success of Tocilizumab in RA Patients With Remission Induction and Sustained Efficacy After Discontinuation (SURPRISE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01120366
Recruitment Status : Completed
First Posted : May 10, 2010
Last Update Posted : January 26, 2015
Sponsor:
Information provided by (Responsible Party):
SURPRISE Study Group

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 2014
Actual Study Completion Date : December 2014
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):